Traumatic Hemorrhage
7
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
29%
2 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department
Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage at Pre-hospital Phase of Care.
Factor In the Initial Resuscitation of Severe Trauma 2 Patients
LAVA TQ Doppler Functionality Study
Study of Tranexamic Acid During Air and Ground Medical Prehospital Transport Trial (STAAMP Trial)
Determine the Most Effective Intervention for Hemorrhage Control Readiness for Laypersons: The PATTS Trial
The Use of rFVIIa in Trauma Patients: A Multi-Center Case Registry